Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

MedImmune building Cambridge

MedImmune and Mirati to partner on lung cancer combo

August 6, 2015 Research and Development AstraZeneca, Cancer, MedImmune, Mirati, Mirati Therapeutics, NSCLC, durvalumab, immuno-oncology, immunotherapy, lung cancer, mocetinostat

MedImmune is entering into an exclusive clinical trial collaboration with US-based Mirati Therapeutics to test a novel immuno-oncology combination in …
News
astrazeneca image

AstraZeneca buys rights to Heptares experimental cancer treatment

August 6, 2015 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Cancer, HTL-1071, immuno-oncology

AstraZeneca has entered into a licensing agreement with Heptares for the global rights to the experimental cancer treatment HTL-1071. The …
News
Shire building

Shire goes public with rejected $30bn Baxalta bid

August 5, 2015 Research and Development, Sales and Marketing Baxalta, Shire, acquisitions, baxter, mergers, rare disease

Shire has confirmed that it made an all-share $30 billion offer to buy Baxalta last month, citing ’a strong strategic …
News

Lilly set for Cymbalta lawsuit showdown

August 5, 2015 Research and Development cymbalta, duloxetine, lawsuit, lilly

Lilly is contesting the first in a series of lawsuits brought by patients who say the company failed to inform …
News
Spritam

First 3D-printed drug approved by FDA

August 4, 2015 Manufacturing and Production, Research and Development 3d printing, FDA, manufacturing, production

The world of medicine saw a new pharma milestone this week, with the first approval by the FDA of a …
News
Teva image

Teva buys majority stake in genomic analysis firm

August 4, 2015 Manufacturing and Production, Research and Development, Sales and Marketing CNS, Immuneering, Teva, central nervous system, genetic analysis

Teva has agreed to by a 51% equity share of genomic-analysis company Immuneering to advance treatments for diseases of the …
News
Shire building

Shire in $300m Foresight acquisition

August 4, 2015 Manufacturing and Production, Research and Development, Sales and Marketing FST-100, Foresight Biotherapeutics, Shire, conjunctivitis, dry eye, lifitegrast, pink eye

Shire has acquired Foresight Biotherapeutics for $300 million, as it looks to build its presence in eye diseases. The acquisition …
News
AZ sign

AstraZeneca and Isis Pharma in $65m drugs collaboration

August 3, 2015 Manufacturing and Production, Research and Development AstraZeneca, Isis Pharma, Isis Pharmaceuticals, antisense, drug R&D

Isis Pharmaceuticals and AstraZeneca have announced a strategic collaboration to discover and develop antisense therapies for cardiovascular, metabolic and renal …
News
WHO flag

Encouraging first results from trial of Merck’s Ebola vaccine

July 31, 2015 Research and Development, Sales and Marketing Africa, EBV, Ebola, Ebola virus, Ebola virus disease, Vaccine, WHO, World Health Organisation, guinea, vaccination

The first trial of an experimental Ebola vaccine suggests it provides high protection against the disease as early as ten …
News

BMS to trial Opdivo in solid tumours

July 30, 2015 Research and Development BMS, Bristol-Myers Squibb, Kyowa Hakko Kirin, Poteligeo, mogamulizumab, nivolumab, opdivo, solid tumours

Bristol-Myers Squibb will begin early-phase trials of its immuno-oncology treatment Opdivo with other cancer treatments, to see if the combination …
News
Takeda oncology

Takeda cancer drug gets EMA boost

July 29, 2015 Research and Development, Sales and Marketing Takeda, ixazomib, multiple myeloma

The EMA has granted Takeda an accelerated assessment for its multiple myeloma drug, ixazomib. The Agency’s Committee for Medicinal Products …
News

David Khougazian announced as president of Sanofi Pasteur MSD

July 29, 2015 Business Services, Research and Development, Sales and Marketing MSD, Merck, Sanofi Pasteur

Sanofi Pasteur and Merck have appointed David Khougazian as president of their joint company, Sanofi Pasteur MSD. David Khougazian joined …
Appointment
dr_james_shannon

Dr James Shannon joins Immodulon Therapeutics board of directors

July 29, 2015 Research and Development, Sales and Marketing Immodulon

Dr James Shannon has joined Immodulon as a non-executive director with immediate effect. Bringing with him 30 years’ of experience …
Appointment
UCB

Mixed Phase 3 results for Sanofi and UCB

July 29, 2015 Research and Development LixiLan, Sanofi, UCB, clinical trials, epratuzumab, insulin, insulin glargine, phase III

Two drugs that pharma companies are pinning hopes on for future success have had mixed outcomes in key late-stage clinical …
News
Novartis window

Novartis forms Mereo as UK biotech spin-off

July 29, 2015 Research and Development Mereo, Novartis, biotech, rare diseases

Novartis has formed a new UK biotech company by selling three investigational drugs in exchange for shares in the new …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026